JP4049391B2 - 非経口的薬剤の製造のための方法及び装置 - Google Patents

非経口的薬剤の製造のための方法及び装置 Download PDF

Info

Publication number
JP4049391B2
JP4049391B2 JP51854497A JP51854497A JP4049391B2 JP 4049391 B2 JP4049391 B2 JP 4049391B2 JP 51854497 A JP51854497 A JP 51854497A JP 51854497 A JP51854497 A JP 51854497A JP 4049391 B2 JP4049391 B2 JP 4049391B2
Authority
JP
Japan
Prior art keywords
nozzle
homogenizer
dispersion
steel body
cavity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP51854497A
Other languages
English (en)
Japanese (ja)
Other versions
JP2000500146A (ja
JP2000500146A5 (enExample
Inventor
クリンクジーク,ベルント
マヒアウト,ザイト
ノテレ,リカルダ−クリステイネ
ハマン,ハンス−ユルゲン
スデビク,ユルゲン
Original Assignee
バイエル・アクチエンゲゼルシヤフト
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by バイエル・アクチエンゲゼルシヤフト filed Critical バイエル・アクチエンゲゼルシヤフト
Publication of JP2000500146A publication Critical patent/JP2000500146A/ja
Publication of JP2000500146A5 publication Critical patent/JP2000500146A5/ja
Application granted granted Critical
Publication of JP4049391B2 publication Critical patent/JP4049391B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/44221,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4709Non-condensed quinolines and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1277Preparation processes; Proliposomes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01FMIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F25/00Flow mixers; Mixers for falling materials, e.g. solid particles
    • B01F25/40Static mixers
    • B01F25/46Homogenising or emulsifying nozzles
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01FMIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F33/00Other mixers; Mixing plants; Combinations of mixers
    • B01F33/70Mixers specially adapted for working at sub- or super-atmospheric pressure, e.g. combined with de-foaming
    • B01F33/71Mixers specially adapted for working at sub- or super-atmospheric pressure, e.g. combined with de-foaming working at super-atmospheric pressure, e.g. in pressurised vessels
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/29Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2984Microcapsule with fluid core [includes liposome]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Medicines Containing Plant Substances (AREA)
JP51854497A 1995-11-15 1996-11-04 非経口的薬剤の製造のための方法及び装置 Expired - Fee Related JP4049391B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19542499A DE19542499A1 (de) 1995-11-15 1995-11-15 Verfahren und Vorrichtung zur Herstellung einer parenteralen Arzneistoffzubereitung
DE19542499.9 1995-11-15
PCT/EP1996/004795 WO1997017946A2 (de) 1995-11-15 1996-11-04 Verfahren und vorrichtung zur herstellung einer parenteralen arzneistoff-zubereitung

Publications (3)

Publication Number Publication Date
JP2000500146A JP2000500146A (ja) 2000-01-11
JP2000500146A5 JP2000500146A5 (enExample) 2004-07-15
JP4049391B2 true JP4049391B2 (ja) 2008-02-20

Family

ID=7777475

Family Applications (1)

Application Number Title Priority Date Filing Date
JP51854497A Expired - Fee Related JP4049391B2 (ja) 1995-11-15 1996-11-04 非経口的薬剤の製造のための方法及び装置

Country Status (11)

Country Link
US (1) US6331314B1 (enExample)
EP (1) EP0861068B1 (enExample)
JP (1) JP4049391B2 (enExample)
AT (1) ATE222097T1 (enExample)
CA (1) CA2237554C (enExample)
DE (2) DE19542499A1 (enExample)
DK (1) DK0861068T3 (enExample)
ES (1) ES2180807T3 (enExample)
MX (1) MX9803633A (enExample)
PT (1) PT861068E (enExample)
WO (1) WO1997017946A2 (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1008380T3 (da) 1998-12-07 2004-07-12 Dsm Ip Assets Bv Fremgangsmåde og indretning til blanding eller dispergering af væsker
US20020119188A1 (en) * 2000-02-08 2002-08-29 Susan Niemiec Method of manufacturing liposomes
EP1222957A1 (en) * 2000-12-22 2002-07-17 Société des Produits Nestlé S.A. Process and device for producing a food grade oil-in-water emulsion
DE102004055507A1 (de) * 2004-11-17 2006-05-18 Basf Ag Verfahren zur Herstellung feinteiliger flüssig-flüssig Formulierungen und Vorrichtung zur Herstellung feinteiliger flüssig-flüssig Formulierungen
US20070231823A1 (en) * 2006-03-23 2007-10-04 Mckernan Kevin J Directed enrichment of genomic DNA for high-throughput sequencing
US7985058B2 (en) * 2007-01-12 2011-07-26 Mark Gray Method and apparatus for making uniformly sized particles
US7491856B2 (en) * 2007-06-27 2009-02-17 H R D Corporation Method of making alkylene glycols
US7652175B2 (en) * 2007-06-27 2010-01-26 H R D Corporation High shear process for the production of acetaldehyde
US8304584B2 (en) 2007-06-27 2012-11-06 H R D Corporation Method of making alkylene glycols
US7479576B1 (en) 2007-06-27 2009-01-20 H R D Corporation Method of hydrogenating aldehydes and ketones
CN101687153A (zh) * 2007-06-28 2010-03-31 宝洁公司 通过产生剪切和/或气穴进行混合的设备和方法以及用于设备的组件
US8322910B2 (en) 2008-07-25 2012-12-04 The Procter & Gamble Company Apparatus and method for mixing by producing shear and/or cavitation, and components for apparatus
CN101617990B (zh) * 2009-07-31 2013-01-23 中国人民解放军第三军医大学 脂质体制备装置以及使用该装置制备脂质体的方法
JP5771366B2 (ja) * 2009-09-02 2015-08-26 株式会社バイオメッドコア リポソーム製造装置及び方法
US10213383B2 (en) 2009-12-03 2019-02-26 Novartis Ag Hydrophilic filtration during manufacture of vaccine adjuvants
DE102009056884B4 (de) * 2009-12-03 2021-03-18 Novartis Ag Impfstoff-Adjuvantien und verbesserte Verfahren zur Herstellung derselben
EP4410306A3 (en) 2009-12-03 2024-11-13 Seqirus UK Limited Circulation of components during homogenization of emulsions
DE102009056871A1 (de) 2009-12-03 2011-06-22 Novartis AG, 4056 Impfstoff-Adjuvantien und verbesserte Verfahren zur Herstellung derselben
CL2012001399A1 (es) 2009-12-03 2013-03-08 Novartis Ag Metodo para fabricar adyuvante para vacuna (emulsion aceite/agua con escualeno, polisorbato 80 y trioleato de sorbitan), que comprende (i) formar primera emulsion en homogenizador desde un contendor a otro para formar segunda emulsion, (ii) y microfluidizar primera emulsion para formar segunda emulsion.
DE102009056883B4 (de) 2009-12-03 2012-08-16 Novartis Ag Impfstoff-Adjuvantien und verbesserte Verfahren zur Herstellung derselben
CN120529961A (zh) * 2023-01-17 2025-08-22 帝斯曼知识产权资产管理有限公司 液体分散体制备工艺

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4529561A (en) * 1978-03-24 1985-07-16 The Regents Of The University Of California Method for producing liposomes in selected size range
WO1983000089A1 (en) * 1981-07-06 1983-01-20 Rush Presbyterian St Luke Preparation of synthetic erythrocytes
CA1264668A (en) * 1984-06-20 1990-01-23 Pieter R. Cullis Extrusion techniques for producing liposomes
DE3515335C2 (de) 1985-04-27 1995-01-26 Bayer Ag Arzneizubereitung enthaltend Dihydropyridine und Verfahren zu ihrer Herstellung
DE4207481A1 (de) * 1992-03-10 1993-09-16 Bayer Ag Liposomale wirkstoff-formulierungen und verfahren zu ihrer herstellung
DE4328331A1 (de) * 1993-08-18 1995-02-23 Andreas Dr Sachse Kontinuierliches Hochdruckextrusionsverfahren zur Herstellung von Liposomen und Emulsionen
JPH08505312A (ja) * 1992-10-16 1996-06-11 ザックセ,アンドレアス 液状分散系を製造する方法及び装置

Also Published As

Publication number Publication date
WO1997017946A3 (de) 1997-09-12
JP2000500146A (ja) 2000-01-11
EP0861068A2 (de) 1998-09-02
MX9803633A (es) 1998-09-30
CA2237554A1 (en) 1997-05-22
DK0861068T3 (da) 2002-12-02
EP0861068B1 (de) 2002-08-14
DE59609564D1 (de) 2002-09-19
US6331314B1 (en) 2001-12-18
DE19542499A1 (de) 1997-05-22
WO1997017946A2 (de) 1997-05-22
CA2237554C (en) 2007-01-09
PT861068E (pt) 2002-12-31
ATE222097T1 (de) 2002-08-15
ES2180807T3 (es) 2003-02-16

Similar Documents

Publication Publication Date Title
JP4049391B2 (ja) 非経口的薬剤の製造のための方法及び装置
JP3977418B2 (ja) 飽和溶解度と溶解速度を増大させた薬剤投与用ナノ懸濁液
RU2114612C1 (ru) Терапевтическая или диагностическая композиция
EP1652515A1 (en) Process for producing drug ultramicroparticle and apparatus therefor
US8034381B2 (en) Method for producing ultrafine submicronic suspensions
CN100512798C (zh) 亚微米颗粒悬浮液制备方法
CN1761454A (zh) 小颗粒的制备方法
SK139093A3 (en) Agent containing nanoparticles and method of its manufacture
JPH08268915A (ja) 製剤の基剤
JP2007512241A (ja) 本質的に溶媒を含まない小粒子の製造のためのプロセス
EP1688169A1 (en) Method for producing fine organic compound particles
CA2519536A1 (en) Methods for the comminution and stabilization of small particles in suspension
EP2196194B1 (en) Process for producing biological ingesta and biological ingesta obtained thereby
JP2001205061A (ja) パーフルオロカーボン乳化製剤の製造法
JPH11139961A (ja) リポソームの製造方法
Masson Advanced techniques for preparation and characterization of small unilamellar vesicles
CN120284922A (zh) 一种吸入用布地奈德混悬液及其制备方法
JPH06271460A (ja) リポソーム分散液の製造方法
AU2762700A (en) Pharmaceutical nanosuspensions for medicament administration as systems of increased saturation solubility and rate of solution
MXPA96001033A (en) Nanosuspensions for intraven administration

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20070206

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20070501

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20070618

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20070605

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20070723

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20070806

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20071120

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20071127

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20101207

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20101207

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20111207

Year of fee payment: 4

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20121207

Year of fee payment: 5

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20121207

Year of fee payment: 5

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313113

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20131207

Year of fee payment: 6

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20131207

Year of fee payment: 6

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees